RankAlpha logo
Back to Rankings

NVO

Novo Nordisk A/SC
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
NVO vs peer average
36/100
NVO vs. peer average (C vs. B)
Grade spread
A 4 · B 3 · C 1 · D 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AMGN is the first available peer comparator.

A same-indication late-stage pipeline comparator, not a current obesity-sales peer. Amgen reports Phase 3 MariTide obesity studies, including a trial of patients switching from semaglutide or tirzepatide; those studies make dosing and maintenance relevant to Novo's future competitive position. [Amgen results](https://www.amgen.com/newsroom/press-releases/2026/08/amgen-reports-second-quarter-2026-financial-results).

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAMGNAmgen
NVO
Novo Nordisk A/S
AMGN
Amgen
Grade
C
D
Momentum
24
91
Value
65
61
Sentiment
50
27
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Open Side-by-Side ComparisonCompare top peers (up to 3)

Grade position vs AMGN

NVO / AMGN
Grade Position
Below peers
NVO vs. peer average (C vs. B)
36/100
Momentum
24
AMGN
Value
65
NVO
Sentiment
50
NVO

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NVO
1
AMGN
AMGN
D
40/100
-1
2
LLY
LLY
A
100/100
+2
3
VKTX
VKTX
D
40/100
-1
4
PFE
Pfizer Inc Common
B
80/100
+1
5
DHR
Danaher Corp Common
A
100/100
+2
AMGN is the first peer returned for this comparison set.